Affordable Prescriptions for Patients Act

Summary

Official

Affordable Prescriptions for Patients Act This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to...

How would you vote on this bill?

Yes No

Bill Progress

Committee is reviewing, marking up, or holding hearings on the bill

Introduced(3/13/25)

Committee

Passed House

Passed Senate

President

Law